Rongrong Zheng is specialized in capital markets, M&A, PE/VC, and general corporate matters. Industries involved include real estate, healthcare, high technology, TMT, manufacturing, education, retail and consuming, etc.

In the field of capital markets, Rongrong Zheng has advised on the restructuring and the public offering and listing of shares of a number of enterprises, including Fangdd, Nayuki, General Education, Jin Medical, Connect Biopharma, ZJK Industrial, Fineland Real Estate Services Group, etc.

In the field of bond issuances, Rongrong Zheng has participated in series of offshore dollar bond issuance projects including LvGem, Guangdong-Hong Kong Greater Bay Area Holding, Helenbergh Real Estate, MicroPort Scientific Corporation, etc.

Rongrong Zheng has been significantly involved in a number of transactions including Shenzhen Capital Value Partners Greater Bay Area Opportunity Limited Partnership Fund’s acquisition of 2.09% issued shares of Fengxiang Co (09977.HK), PanAsialum Holdings Company Limited’s (02078.HK) sale of its domestic subsidiaries, Shenzhen Yuanzhi Xinghuo Private Equity Investment Fund’s domestic investment projects, several SF Express’s domestic investment projects, etc.

Rongrong Zheng joined Global Law Office in 2019. Prior to joining Global, Rongrong Zheng worked with Kangda Law firm in the areas of capital markets.

Admitted in the PRC

2017-2018  The Chinese University of Hong Kong, LL.M.

2013-2017  Sun Yat-sen University, LL.B.